Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

AVE

Aventis (AVE)

Aventis New Ads

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:AVE

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
15/10/2004	23h03	PR Newswire (US)	Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A	NYSE:AVE	Aventis New Ads
04/10/2004	21h44	PR Newswire (US)	Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers	NYSE:AVE	Aventis New Ads
22/09/2004	23h23	PR Newswire (US)	Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease	NYSE:AVE	Aventis New Ads
21/09/2004	15h30	PR Newswire (US)	Aventis Named to List of Top 100 Companies for Working Mothers	NYSE:AVE
16/09/2004	09h00	PR Newswire (US)	The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity	NYSE:AVE
14/09/2004	15h30	PR Newswire (US)	Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Disease	NYSE:AVE	Aventis New Ads
19/08/2004	15h00	PR Newswire (US)	FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer	NYSE:AVE	Aventis New Ads
11/08/2004	17h39	PR Newswire (US)	Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adole	NYSE:AVE	Aventis New Ads
06/08/2004	02h02	PR Newswire (US)	Ventiv Health Announces Sales and Marketing Agreement with Aventis	NYSE:AVE	Aventis New Ads
03/08/2004	20h58	PR Newswire (US)	FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid)	NYSE:AVE	Aventis New Ads
28/07/2004	21h31	PR Newswire (US)	Aventis Reports Second-Quarter and First-Half Results for 2004	NYSE:AVE	Aventis New Ads
27/07/2004	17h29	PR Newswire (US)	Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent	NYSE:AVE
07/07/2004	15h00	PR Newswire (US)	New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes	NYSE:AVE
23/06/2004	16h50	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers	NYSE:AVE
14/06/2004	17h43	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend	NYSE:AVE
07/06/2004	19h00	PR Newswire (US)	Two Landmark Studies Show That Taxotere(R) Significantly Improves Survival in Men With Prostate Cancer	NYSE:AVE	Aventis New Ads
05/06/2004	16h00	PR Newswire (US)	Investigators Report Taxotere(R) Offers Significant Survival Benefits for Head and Neck Cancer Patients	NYSE:AVE	Aventis New Ads
01/06/2004	21h40	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers	NYSE:AVE
28/05/2004	19h00	PR Newswire (US)	Genta and Aventis Announce Termination of Genasense(TM) Expanded Access Program in Melanoma	NYSE:AVE	Aventis New Ads
27/05/2004	09h00	PR Newswire (US)	Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine Agreement	NYSE:AVE
26/05/2004	17h05	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004	NYSE:AVE
26/05/2004	15h00	PR Newswire (US)	Two Landmark Studies of Taxotere(R) in Prostate Cancer Highlighted in American Society of Clinical Oncology Plenary Session	NYSE:AVE	Aventis New Ads
23/05/2004	19h15	PR Newswire (US)	Data Show Once-Daily Alvesco(R) (ciclesonide) Has No Effect on HPA-Axis Function in Asthma Patients	NYSE:AVE
23/05/2004	19h15	PR Newswire (US)	Surveillance Study Finds Newly-Approved Antibiotic KETEK(R) (telithromycin) Tablets 99% Effective In Vitro Against Streptococcus	NYSE:AVE
19/05/2004	21h39	PR Newswire (US)	Aventis Receives FDA Approval for Taxotere(R) in Prostate Cancer	NYSE:AVE	Aventis New Ads
18/05/2004	15h01	PR Newswire (US)	Aventis Receives Priority Review Designation for the Registrational Application to Support the Use of Taxotere(R) in Women with	NYSE:AVE
05/05/2004	17h12	PR Newswire (US)	Sanofi-Synthelabo's Offer for Aventis	NYSE:AVE
03/05/2004	21h52	PR Newswire (US)	FDA Advisory Committee Reviews Genasense(TM) for Use in Advanced Melanoma	NYSE:AVE	Aventis New Ads
30/04/2004	21h55	PR Newswire (US)	Aventis Pasteur Statement on New Influenza Immunization Recommendations for Infants, Young Children and Their Close Contacts	NYSE:AVE
29/04/2004	20h03	PR Newswire (US)	Aventis Reports First-Quarter Results for 2004	NYSE:AVE

Showing the most relevant articles for your search:NYSE:AVE

Deutsche Lufthansa

Euro vs US Dollar

Financial Select Sector

BNP Paribas (QX)

JP Morgan Chase

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen